Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

G. Kulkarni · SciRah

Researcher profile · Semantic Scholar

G. Kulkarni

Share profile

G. Kulkarni — researcher profile on SciRah

h-index: 7
Works: 26
Citations: 506

Most-cited papers

Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis.
A. Zlotta, L. Ballas, A. Niemierko, K. Lajkosz +25 more
2023The Lancet Oncology208 citations
Semantic Scholar
Diagnosis and Management of Non-Metastatic Upper Tract Urothelial Carcinoma: AUA/SUO Guideline
J. Coleman, Peter E. Clark, B. Bixler, D. Buckley +11 more
2023Journal of Urology203 citations
Semantic Scholar
Obesity is associated with larger prostate volume but not with worse urinary symptoms: analysis of a large multiethnic cohort.
B. Bhindi, D. Margel, Greg Trottier, R. Hamilton +9 more
2014Urology29 citations
Semantic Scholar
Modifiable lifestyle behaviours impact the health‐related quality of life of bladder cancer survivors
J. Chung, G. Kulkarni, J. Bender, R. Breau +6 more
2020BJU International19 citations Open access
Semantic Scholar
A first-in-human trial of intravesical enfortumab vedotin (EV), an antibody-drug conjugate (ADC), in patients with non-muscle invasive bladder cancer (NMIBC): Interim results of a phase 1 study (EV-104).
A. Kamat, Y. Lotan, M. Rouprêt, Gary D. Steinberg +12 more
2023Journal of Clinical Oncology13 citations Open access
Semantic Scholar
Radiation-based Therapy for Muscle-invasive Bladder Cancer: Contemporary Outcomes Across Tertiary Centers.
R. Kool, G. Marcq, R. Breau, P. Black +15 more
2023European Urology Oncology11 citations
Semantic Scholar
Robotic Versus Open Cystectomy for Bladder Cancer: Synthesizing the Data from Current Systematic Reviews and Meta-Analyses
K. Aminoltejari, A. Hird, Z. Klaassen, R. Satkunasivam +5 more
2023Annals of Surgical Oncology9 citations
Semantic Scholar
Cost of Bladder Cancer Care: A Single-center Comparison of Radical Cystectomy and Trimodal Therapy
D. Magee, D. Cheung, A. Hird, P. Chung +6 more
2023Urology Practice6 citations
Semantic Scholar
Differences in contemporary biopsy Gleason score distribution in large cohorts of men diagnosed with prostate cancer from China and Canada
L. Dong, Wei Xu, D. Woon, C. Kuk +15 more
20205 citations Open access
Semantic Scholar
Updated follow-up from KEYNOTE-057: Phase 2 study of pembrolizumab (pembro) for patients (pts) with high-risk (HR) non–muscle invasive bladder cancer (NMIBC) unresponsive to bacillus Calmette-Guérin (BCG)
J. Boormans, R. de Wit, G. Kulkarni, E. Uchio +14 more
20203 citations Open access
Semantic Scholar
Free PSA Ratio as a Predictor of Adverse Outcomes after Curative-Intent External Beam Radiation Therapy for Prostate Cancer: A Novel Application of an "Old" Biomarker
H. Goldberg, R. Glicksman, N. Fleshner, D. T. S. Woon +12 more
2018International Journal of Radiation Oncology, Biology, Physics2 citations
Semantic Scholar
LBA37 A phase II study of avelumab in locally advanced or metastatic penile cancer patients unfit for platinum-based chemotherapy or progressed on or after platinum-based chemotherapy (ALPACA)
S. Sridhar, C. Stecca, R. Fernandes, D. Jiang +8 more
2025Annals of Oncology1 citations
Semantic Scholar
PD09-03 INVERSE PROBABILITY TREATMENT WEIGHTING COMPARISON OF RADICAL CYSTECTOMY TO TRIMODALITY THERAPY FOR CT2-CT4 MUSCLE INVASIVE BLADDER CANCER
A. Zlotta, L. Ballas, A. Niemierko, K. Lajkosz +27 more
2023Journal of Urology1 citations
Semantic Scholar
Phase 2 Trial of Metastasis Directed Therapy for Molecularly Defined Oligometastatic Prostate Cancer
R. Glicksman, U. Metser, X.-Y. Ye, P. Chung +23 more
2026International Journal of Radiation Oncology, Biology, Physics0 citations
Semantic Scholar
P0698 Post-hoc Bayesian re-analysis of 21-year follow-up data from the Rotterdam section of the ERSPC: Examining robustness of findings to varying prior assumptions
D.-D. Nguyen, M. Roobol, A. Zlotta, L. Rosella +3 more
2026European Urology0 citations
Semantic Scholar
Inverse probability treatment weighting comparison of radical cystectomy to trimodality therapy for cT2-cT4 muscle invasive bladder cancer
A. Zlotta, L. Ballas, A. Niemierko, K. Lajkosz +21 more
2023European Urology0 citations
Semantic Scholar
LBA03-08 PEMBROLIZUMAB (PEMBRO) FOR PATIENTS (PTS) WITH HIGH-RISK NON-MUSCLE-INVASIVE BLADDER CANCER (HR NMIBC) UNRESPONSIVE TO BACILLUS CALMETTE-GUERIN (BCG): EFFICACY AND EVALUATION OF SUBSEQUENT CYSTECTOMY FROM COHORT B OF THE PHASE 2 KEYNOTE-057 STUDY
E. Singer, A. Necchi, M. Roumiguié, A. A. Esen +16 more
2023Journal of Urology0 citations
Semantic Scholar
PD-0565 Outcomes of the use of partial boost in radical radiotherapy in muscle invasive bladder cancer.
I. Navarro, S. Arulanantham, Z. Liu, M. Tjong +12 more
2023Radiotherapy and Oncology0 citations
Semantic Scholar
PD09-02 THE IMPACT OF VARIANT HISTOLOGY ON CLINICAL OUTCOMES AFTER RADIATION-BASED THERAPY FOR MUSCLE-INVASIVE BLADDER CANCER
D. Halstuch, R. Kool, G. Marcq, R. Breau +16 more
2023Journal of Urology0 citations
Semantic Scholar
Propensity matched comparison of radical cystectomy with trimodality therapy for muscle invasive bladder cancer (MIBC): A multi-institutional study
A. Zlotta, L. Ballas, A. Niemierko, K. Lajkosz +19 more
2022European Urology0 citations
Semantic Scholar
Predictors of re-resection in primary T1 bladder cancer: Identifying patients who do not receive guideline-concordant care at the population level
M. Wettstein, N. Baxter, R. Sutradhar, M. Mamdani +8 more
20200 citations Open access
Semantic Scholar
Non-muscle invasive bladder cancer recurrences in patients managed with trimodal therapy: Conservative or radical treatment?
K. Ajib, M. B. Berjaoui, J. Caceres, M. Tjong +9 more
20200 citations Open access
Semantic Scholar
PO-1213: Pelvic radiotherapy in node positive bladder cancer – outcomes in a selected cohort
M. Tjong, I. Lunsky, K. Ajib, S. Sridhar +5 more
2020Radiotherapy and Oncology0 citations
Semantic Scholar
Selective Use of Radiation-Based Management in Localized Muscle-Invasive Bladder Cancer
M. Tjong, I. Lunsky, K. Ajib, A. Erlich +7 more
2019International Journal of Radiation Oncology, Biology, Physics0 citations
Semantic Scholar
Differences in contemporary biopsy Gleason score distribution in men diagnosed with prostate cancer from China and Canada
L. Dong, D. Woon, C. Kuk, A. Erlich +12 more
2019European urology. Supplement0 citations
Semantic Scholar
A non-invasive urine-based methylation biomarker panel to detect bladder cancer and discriminate cancer grade
T. Hermanns, Andrea J. Savio, E. Olkhov‐Mitsel, Andrea Mari +19 more
2019European urology. Supplement0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

N. Fleshner×12
Invite
N. Fleshner — researcher profile on SciRah
C. Kuk×7
Invite
C. Kuk — researcher profile on SciRah
C. Catton×7
Invite
C. Catton — researcher profile on SciRah
P. Chung×7
Invite
P. Chung — researcher profile on SciRah

×6

Invite

A. Zlotta — researcher profile on SciRah

Invite

A. Zlotta — researcher profile on SciRah

Invite

A. Berlin — researcher profile on SciRah

Invite

A. Finelli — researcher profile on SciRah

Invite

A. Berlin — researcher profile on SciRah

Invite

L. Ballas — researcher profile on SciRah

A. Niemierko×4

Invite

A. Niemierko — researcher profile on SciRah

Invite

K. Lajkosz — researcher profile on SciRah